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ABSTRACT
Introduction: A novel neurostimulation system allows
steering current in horizontal directions by combining
segmented leads and multiple independent current
control. The aim of this study was to evaluate direc-
tional DBS effects on parkinsonian motor features and
adverse effects of subthalamic neurostimulation.
Methods: Seven PD patients implanted with the novel
directional DBS system for bilateral subthalamic DBS
underwent an extended monopolar review session dur-
ing the first postoperative week, in which current
thresholds were determined for rigidity control and
stimulation-induced adverse effects using either direc-
tional or ring-mode settings.
Results: Effect or adverse effect thresholds were modi-
fied by directional settings for each of the 14 STN leads.
Magnitude of change varied markedly between leads,
as did orientation of optimal horizontal current steering.
Conclusion: Directional current steering through chron-
ically implanted segmented electrodes is feasible,
alters adverse effect and efficacy thresholds in a highly
individual manner, and expands the therapeutic
window in a monopolar review as compared to ring-
mode DBS. VC 2016 The Authors. Movement Disorders
published by Wiley Periodicals, Inc. on behalf of Inter-
national Parkinson and Movement Disorder Society
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DBS of the STN has proven to be a safe, effective
treatment for patients with severe tremor, motor
fluctuations, or dyskinesia in Parkinson’s disease.1,2
However, individual outcomes may vary greatly and
critically depend on the brain volume being stimulat-
ed. Best motor symptom control has been associated
with stimulation of the dorsolateral STN,3,4 whereas
current leaking into adjacent fiber tracts can cause
adverse effects such as dysarthria, impaired fine motor
control, or oculomotor disturbances.5
Conventional DBS systems use ring-shaped electrodes,
which generate an approximately spherical electrical
field. In these systems, programming of polarity and
stimulation pulse parameters allows only limited control
of the shape of the volume of tissue activated.6 Recently,
two acute intraoperative studies have proven the feasi-
bility of horizontal current steering by using novel lead
designs, such as segmented or multicontact electrodes.7,8
Directed stimulation using these electrodes resulted in
increased stimulation thresholds for side effects as com-
pared to standard spherical stimulation.
Here, we report our first clinical experience of direc-
tional DBS with a novel, fully implantable neurostimu-
lation system (Vercise PC; Boston Scientific, Valencia,
CA), which combines eight-contact directional leads
and a pulse generator capable of multiple independent
current source control (MICC). The system received a
CE Mark in September 2015, and the first device was
implanted at our center on 16 September 2015.
The novel directional DBS lead has four electrode
levels, of which the two middle levels are split into
three segments spanning approximately 120 degrees,
whereas the highest and lowest level consist of ring-
shaped electrodes (Supporting Fig. 1A). MICC allows
to distribute the stimulation current over any combi-
nation of electrodes of one lead in arbitrary propor-
tions. An equal distribution of current among all three
segments at one level simulates a ring-shaped elec-
trode, whereas maximal horizontal steering effects are
obtained when current is distributed to one or two
segments at one level (Supporting Fig. 1B). Our retro-
spective analysis of monopolar review data aimed at
quantifying the effect of horizontal current steering on
the therapeutic window of STN-DBS as compared to
conventional ring mode stimulation.
Patients and Methods
Seven PD patients (2 female; age, 47–64 years; disease
duration: 8–20 years; UPDRS-III Med off: 42; UPDRS-
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III Med on: 19), who had been implanted with the direc-
tional Vercise PC (Boston Scientific) for bilateral STN-
DBS between September and December 2015, under-
went an extended programming session of their DBS
system in the practically defined medication off state
(>12 hours of medication withdrawal) 4 to 9 days (mean,
7 6 2) postsurgery. The programming session was sched-
uled when the stun effect of electrode placement was
decreasing and testable off period motor symptoms had
returned in each patient in at least one body side.
The programming session followed the procedure of a
standard monopolar review,6 in which for each electrode
configuration current thresholds are determined for com-
plete rigidity control (efficacy threshold) and the first
adverse event (AE) limiting further current increase (AE
threshold). Frequency and pulse width were constantly
set to 130 Hz and 60 ls, respectively, and the implant-
able pulse generator case was always programmed as
anode. Stimulation current was increased/decreased in
steps of 0.5 mA until complete rigidity suppression (i.e.,
hypotonia of the upper extremity) was achieved or an
AE of stimulation was reported by the patient or
observed on clinical examination. Then, the current
threshold was fine tuned in smaller steps of 0.1 mA.
Using this procedure, we first determined the thera-
peutic window (TW; current difference between effica-
cy and AE threshold in mA) for the two segmented
levels of each lead in ring mode (equally distributing
current among the three segments of a level) and
labeled the level with the larger TW as “most effective
ring level.” Then, different stimulation directions at
each level were tested by either restricting cathodal
current to each of the three segments (first patient) or
additionally evaluating equal current distributions
between two adjacent segments (subsequent 6
patients). This programming results in up to six direct-
ed electrical fields with a field vector rotated by either
120 or 60 degrees (Supporting Figs. 1B and 2). The
sequence of levels or horizontal directions tested was
left to the programming physician’s discretion, who
was unaware of the anatomical position and orienta-
tion of the lead within STN. Threshold amplitudes
were compiled in a datasheet and later used for con-
structing individual polar plots (see Supporting Fig. 2)
and descriptive statistics (paired two-sample t test).
Results
We could determine efficacy thresholds for only 11 of
14 STNs, because a persistent microlesioning effect pre-
vented reliable rigidity assessment in the others, whereas
AE thresholds were determined for all 14 STNs. The AEs
determining the upper limit of the TW were contractions
of facial or hand muscles in 11 of 14 STNs, dysarthria in
6 of 14, and persisting dysesthesia in 1 of 14.
In total, we assessed 154 directional and 28 ring-
mode settings and determined TW for 111 and 24 set-
tings, respectively. For each directional setting, the
proportional change of TW from corresponding ring-
mode stimulation was calculated, with negative values
indicating a reduction and positive values indicating
an increase of the TW. The proportional change was
highly variable between leads and directional settings
and ranged between –100% and 440% (see Table 1).
Interestingly, this change in TW was not only deter-
mined by a variable AE threshold, but also by varia-
tions in the effect threshold (see Supporting Fig. 3).
By fusing the postoperative cranial CT with the pre-
operative MRI (Leksell Surgiplan; Elekta Instrument
AB, Stockholm, Sweden) and identifying the directional
lead marker, we determined the orientation of each lead
within stereotactic space and assigned each directional
setting to an orientation in relation to the anterior com-
missure/posterior commissure (AC-PC) line (e.g., anteri-
or, anterolateral, etc.). This allowed us to identify the
anatomical direction of the current vector providing the
TABLE 1. Best and worst effect on TW
Most Effective Level Less Effective Level

















01 Left 5-6-7 35 post-med –42 post-lat 2-3-4 57 post-med –14 post-lat
01 Right 13-14-15 9 ant –9 post-lat 10-11-12 9 ant –22 post-med
02 Left 5-6-7 28 post-med –48 post-lat 2-3-4 440 post-med –100 post
02 Right 10-11-12 10 ant –50 post-med 13-14-15 100 ant –20 post
03 Right 10-11-12 –6 ant-med –65 post-lat 13-14-15 –3 ant –100 post
04 Right 10-11-12 27 post-med –44 ant-lat 13-14-15 77 post-med 0 ant-lat
05 Left 2-3-4 88 med 0 post-lat 5-6-7 171 ant-med 29 ant
05 Right 13-14-15 –5 post –52 ant-med 10-11-12 135 ant-lat 41 ant
06 Right 13-14-15 –9 lat –75 post-med 10-11-12 47 ant –89 post-med
07 Left 2-3-4 –8 ant-med –72 post-lat 5-6-7 135 post 47 lat
07 Right 13-14-15 9 post –18 post-lat 10-11-12 50 ant-lat 0 post
Changes in therapeutic window (DTW) in best and worst direction and respective orientation of electrical field vector are given for all STN in which effect and
AE threshold could be determined.
post-med, posteromedial; ant, anterior; ant-med, anteromedial; med, medial; post, posterior; lat, lateral; post-lat, posterolateral; ant-lat, anterolateral.
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highest positive change in TW (best orientation) and the
smallest change (worst orientation) for each lead and
level. As expected from variable lead locations within a
variably shaped and oriented STN, there was no uni-
form best direction, and best versus worst orientation
were often, but not always strictly opposite (see Table
1). Most often, the “optimal” field vector was oriented
in an “anterior” or “posteromedial” direction.
After grouping the results of directional stimulation
by ring level, it became apparent that larger TW effects
of optimal current steering could be observed at the less
effective (111 6 122%; median, 77; range, –3 to 440)
as compared to the most effective level (16 6 22%;
median, 9; range, –9 to 88%; see Fig. 1). The notion of
a larger TW with directional DBS is also supported by
a secondary analysis comparing the amplitude range
between efficacy and AE threshold of optimal current
steering at the most effective level compared to ring
mode (4.0 6 1.5 vs. 3.6 6 1.4 mA; P 5 0.06).
Interestingly, the change in TW was driven only by
an increase in AE threshold at the most effective level,
whereas at the less effective level, both efficacy and
AE thresholds, changed significantly in favor of the
optimal direction (1.25 6 1.23 vs. 1.77 6 0.95 mA; P
5 0.05; 5.39 vs. 4.27 6 1.46 mA; P < 0.005)
At the end of the monopolar review, the optimal
directional settings were programmed in all patients
and gradually adjusted according to clinical needs dur-
ing the subsequent days of hospitalization. After a
follow-up of 3 to 6 months (median, 4), all patients
have remained programmed in directional mode with-
out need of rescue programming into ring mode to
improve stimulation efficacy (see Supporting Table 1).
None of the patients are complaining about stimula-
tion induced adverse effects so far.
Discussion
Our results demonstrate, for the first time, the feasibil-
ity of horizontal current steering using a fully implanted
neurostimulation device with directional leads and
MICC technology. Despite the limitations of an acute
monopolar review in the early postoperative period,
they also provide first evidence of a beneficial impact of
directional DBS on the TW. In theory, a larger TW
would offer more programming flexibility for optimizing
the efficacy of DBS and reduce the likelihood of inadver-
tently exceeding the adverse effect threshold, when the
stimulation amplitude is gradually adjusted during the
subsequent stabilization period.6 Hence, directional DBS
should result in more consistent good outcomes and
lower AE rates across groups of patients, whereas it is
unlikely to provide more benefit than an optimally
implanted ring-mode DBS in an individual.
Not unexpectedly, we found a larger effect of directional
DBS at the less beneficial lead level. This indicates that the
individual clinical benefit of directional DBS is best
observed for suboptimal electrode positions resulting in a
narrow TW, for example, if the electrode is placed too lat-
erally within the STN close to the internal capsule. Hence,
directional DBS may be able to compensate within certain
limits for small deviations of the lead from the optimal
functional target, which are a main source of outcome vari-
ability in STN-DBS even in experienced surgical centers.4
However, as a note of caution, the availability of a direc-
tional DBS system must never be an excuse for lowering
the surgical standard and precision of surgical lead place-
ment. In fact, the implantation of the Vercise directional
lead is surgically more challenging, because the active site
has a reduced span, compared to the standard eight-
contact ring lead, and the split contacts need to be exactly
aligned in depth with the dorsolateral motor region of the
STN. Moreover, lead rotation is introduced as an addition-
al degree of freedom during the implantation and needs to
be controlled for by exact alignment of the rotational lead
marker with patient centric landmarks (e.g., AC-PC line).
Other limitations of our study include the unblinded
and subjective clinical rating of rigidity and adverse
effect thresholds, lack of long-term clinical follow-up,
early postoperative time period with a partially persis-
tent stun effect, and small number of subjects. Impor-
tantly, we report feasibility data obtained during an
FIG. 1. Bar graph depicting the relative change of the therapeutic window (%) when steering current in the best vs. worst orientation during the
monopolar review. Please note, the change in therapeutic window for best directional current steering was proportionally larger at the less effective
ring level. On both levels therapeutic windows assessed for the best orientation of current steering differed significantly from those obtained when
stimulating into the worst orientation highlighting a potential clinical usefulness of directional DBS.
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acute stimulation challenge, but no efficacy data on the
use of chronic directional DBS compared to standard
ring DBS. Nevertheless, our findings may provide valu-
able input into the planning of appropriate
clinical trials, which are now needed to establish the
theoretical advantages of directional DBS in clinical
practice and on a group level, but should also take into
account possible disadvantages of the expanded param-
eter space, such as increased programming burden.
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ABSTRACT
Introduction: Pathogenic movement of alpha-synuclein
from the gut to the brain in PD has been proposed. The
appendix has a relatively high density of alpha-synuclein
deposition in neurologically healthy individuals. We
investigated the incidence of PD after appendectomy.
Methods: Using cause-specific hazards regression
models, we compared persons over 35 years of age
who had undergone appendectomy with two groups of
age- and sex-matched individuals having had: (1) a
cholecystectomy and (2) neither procedure. Subse-
quent diagnoses of PD were identified.
Results: Among 42,999 individuals undergoing appendec-
tomy, no difference in risk of PDwas identified compared to
cholecystectomy (hazard ratio5 1.004; 95% confidence
interval: 0.740–1.364). Compared with no procedure, indi-
viduals with appendectomy had a higher incidence of PD
within 5 years, but no significant difference in risk thereafter.
Conclusion: In our study, appendectomy in mid or late
life does not appear to be associated with a reduced
risk of PD. VC 2016 International Parkinson and Move-
ment Disorder Society
Key Words: Parkinson’s disease; appendectomy;
etiology
It has been proposed that the initiating events of
Parkinson’s disease (PD) may occur outside the central
nervous system (CNS), with secondary spread to the
brain through a prion-like process.1 The gastrointesti-
nal tract is a candidate for a location of initiating
events.2,3 In people without PD, Gray and colleagues4
found that alpha-synuclein immunoreactivity was
most abundant in the appendiceal lamina propria
compared to the gastric mucosa or other parts of the
right colon, colocalized with neural markers, and was
close to the luminal surface of the appendix, putting it
in close proximity to any pathogen or triggering event
within the gut. The lack of a blood-tissue barrier in
the appendiceal mucosa would facilitate contact
between a blood-borne agent and the enteric nervous
system and exogenous agents contacting the host
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